All Supplements
    Supplement

    Inulin & FOS (Prebiotic Fiber)New

    Supplement
    Gut Health
    5/10 Evidence

    Inulin and fructo-oligosaccharides (FOS) are fermentable fibres, usually extracted from chicory root, that feed beneficial gut bacteria rather than being digested. They reliably increase Bifidobacterium and help regularity; effects on cholesterol and blood sugar are small and of low certainty. They commonly cause gas and are poorly tolerated by many people with irritable bowel syndrome.

    Mechanism of Action

    Inulin-type fructans pass undigested to the colon, where they are selectively fermented by Bifidobacterium and other bacteria into short-chain fatty acids (acetate, propionate, butyrate). These lower colonic pH, nourish colon cells, increase stool bulk and water content, and may influence appetite hormones, bile-acid handling and mineral absorption.

    Dosing Protocol

    Recommended

    10g per day

    Standard starting dose based on research

    Therapeutic Range

    3

    Minimum

    to

    15

    Maximum

    g per day

    With meals, mixed into food or drink; divide the dose if it causes gas

    Cycling Protocol

    Start at 2-3 g/day and increase by 2-3 g each week to tolerance. No cycling needed; benefits fade within weeks of stopping

    Dosages are general guidelines. Individual requirements vary based on body weight, health status, and specific goals. Start with lower doses and adjust based on response.

    Benefits

    Primary Benefits

    • A 2023 systematic review of chicory-derived inulin-type fructans (50 studies, 3-20 g/day) found a significant increase in Bifidobacterium abundance (SMD 0.83) and improved bowel function in healthy adults; the review was funded by a chicory-fibre supplier
    • Improved stool frequency and softer stools at about 10-12 g/day; the European Food Safety Authority accepts a regularity claim for 12 g/day of native chicory inulin
    • A meta-analysis of 55 randomized trials found a small LDL-cholesterol reduction (-0.14 mmol/L, 95% CI -0.24 to -0.05; 38 trials, 1,879 participants) with very low certainty of evidence

    Secondary Benefits

    Small reduction in fasting glucose, mainly in people with prediabetes or type 2 diabetes (inconsistent across meta-analyses)
    Small reduction in triglycerides
    Possible increase in calcium absorption and satiety (preliminary)

    Safety Information

    Contraindications

    Do not use if any of the following apply:

    • •Irritable bowel syndrome with FODMAP sensitivity, or a low-FODMAP diet
    • •Suspected small-intestinal bacterial overgrowth (SIBO)
    • •Active flare of inflammatory bowel disease, or bowel obstruction
    • •Known inulin or chicory allergy (rare)

    Drug/Supplement Interactions

    May interact with the following. Consult a healthcare provider before combining:

    Diabetes medications - small additive glucose lowering; monitor
    Antibiotics - reduce the bacteria that ferment inulin; effect may be blunted during a course
    Other fermentable fibres and sugar alcohols - additive gas and bloating

    Potential Side Effects

    Some users may experience:

    Gas and bloating (dose-dependent, common)
    Abdominal cramping
    Loose stools at higher doses
    Rarely, allergic reaction

    This is not a complete list of interactions or side effects. Individual responses vary. Always start with the lowest effective dose and monitor your response. Report any adverse effects to your healthcare provider.

    Quality Markers

    Look for these specific quality indicators when sourcing this compound:

    • Source and type stated (chicory inulin, oligofructose/FOS, or a blend)
    • Grams of fibre per serving clearly labelled
    • No added sugars or sugar alcohols
    • Third-party tested for purity

    Trusted Certifications

    NSF Certified
    USP Verified
    GMP Certified
    ConsumerLab Approved

    Note: Supplement quality varies dramatically between brands. Cheap supplements often contain fillers, incorrect doses, or contaminants. Investing in quality products from reputable manufacturers is essential for safety and efficacy.

    Evidence Profile

    Evidence Score

    5/10

    Moderate Evidence

    Some clinical trials with positive results, emerging research

    Classification:
    Moderate for bifidogenic and bowel-regularity effects, Emerging for metabolic outcomes (scored 5). The increase in Bifidobacterium and stool frequency is consistent across many small trials, though the largest review was industry-funded with funder staff as co-authors. Lipid and glucose effects are small and rated low to very low certainty; a 2016 meta-analysis of 20 trials found only LDL changed, with a glucose signal confined to type 2 diabetes. Trials are short, doses and fibre chain lengths vary, and no trial shows an effect on disease outcomes. Search was summary-level and should be confirmed against the full papers. Evidence

    Evidence Scale

    8-10

    Strong

    5-7

    Moderate

    1-4

    Emerging

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation